Loading market dashboard
CRISM Therapeutics Corporation
CRTX.LHealthcareLSEVG
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
CRISM Therapeutics Corporation · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $8.2K | $8.2K - $8.2K | $1.6K | -$0.014 | 1 |
| Dec 2028 | $9.8K | $9.8K - $9.8K | $2.0K | -$0.014 | 1 |
| Dec 2027 | $11.7K | $11.7K - $11.7K | $2.3K | -$0.015 | 1 |
| Dec 2026 | $14.0K | $14.0K - $14.0K | $2.8K | -$0.01 | 1 |
| Dec 2025 | $16.7K | $16.7K - $16.7K | $3.3K | -$0.03 | 1 |
| Dec 2024 | $20.0K | $20.0K - $20.0K | $4.0K | -$0.028 | 1 |